These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14618087)

  • 1. Absence of p53 alterations in nasopharyngeal carcinoma Spanish patients with Epstein-Barr virus infection.
    Burgos JS
    Virus Genes; 2003 Dec; 27(3):263-8. PubMed ID: 14618087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma.
    Niemhom S; Kitazawa S; Murao S; Kunachak S; Maeda S
    Cancer Lett; 2000 Nov; 160(2):199-208. PubMed ID: 11053650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 and nasopharyngeal carcinoma: a Malaysian study.
    Hoe SL; Lee ES; Khoo AS; Peh SC
    Pathology; 2009; 41(6):561-5. PubMed ID: 19900105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus infection and P53 expression in HIV-related oral large B cell lymphoma.
    Calzolari A; Papucci A; Baroni G; Ficarra G; Porfirio B; Chiarelli I; Di Lollo S
    Head Neck; 1999 Aug; 21(5):454-60. PubMed ID: 10402527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of p53 and BCL-2 expression with Epstein-Barr virus infection in the cancers of head and neck.
    Yang HJ; Cho YJ; Kim HS; Chang MS; Sung MW; Kim WH
    Head Neck; 2001 Aug; 23(8):629-36. PubMed ID: 11443745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of EBV latency by EBER in situ hybridization in nasopharyngeal carcinoma Spanish patients.
    Burgos JS; Vera-Sempere FJ
    Anticancer Res; 2001; 21(6A):3921-4. PubMed ID: 11911270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1), p16 and p53 proteins in nonendemic nasopharyngeal carcinoma (NPC): a clinicopathological study.
    Rosales-Pérez S; Cano-Valdez AM; Flores-Balcázar CH; Guedea-Edo F; Lino-Silva LS; Lozano-Borbalas A; Navarro-Martín A; Poitevin-Chacón A
    Arch Med Res; 2014 Apr; 45(3):229-36. PubMed ID: 24606815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical absence of CD21 membrane receptor in nasopharyngeal carcinoma cells infected by Epstein-Barr virus in Spanish patients.
    Burgos JS; Vera-Sempere FJ
    Laryngoscope; 2000 Dec; 110(12):2081-4. PubMed ID: 11129025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Epstein-Barr virus infection with p53 protein accumulation but not bcl-2 protein in nasopharyngeal carcinoma.
    Murono S; Yoshizaki T; Park CS; Furukawa M
    Histopathology; 1999 May; 34(5):432-8. PubMed ID: 10231418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A molecular study of EBV DNA and p53 mutations in nasopharyngeal carcinoma of Saudi Arab patients.
    Nasrin N; Taiba K; Hannan N; Hannan M; al-Sedairy S
    Cancer Lett; 1994 Jul; 82(2):189-98. PubMed ID: 7914150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bcl-2, p53 expression and Epstein-Barr virus infection in primary nasopharyngeal carcinoma].
    Cheng Q; Liu G; Wu Z; Wu Y; Xiao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2001 Oct; 15(10):455-7. PubMed ID: 12541691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer.
    Yip KW; Shi W; Pintilie M; Martin JD; Mocanu JD; Wong D; MacMillan C; Gullane P; O'Sullivan B; Bastianutto C; Liu FF
    Clin Cancer Res; 2006 Oct; 12(19):5726-32. PubMed ID: 17020977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma.
    Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ
    Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [MDM2 gene expression in nasopharyngeal carcinoma and its relationship with p53 protein expression and EB virus latent infection].
    Luo JL; Xiao JY; Tian YQ; Zhao SP; Liu JW; Tao ZD
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Nov; 14(11):507-9. PubMed ID: 12563945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis.
    Burgos JS
    Med Oncol; 2005; 22(2):113-21. PubMed ID: 15965273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of the Epstein-Barr virus and tumor suppressor gene p53 gene in nasopharyngeal squamous cell carcinoma.
    Liu J; Liu Y; Zhang Z; Sun H; Ji X; Li B; Zhou X; Gai P
    J Cancer Res Ther; 2019; 15(2):426-436. PubMed ID: 30964122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathology parameters in human nasopharyngeal carcinoma.
    Shi W; Pataki I; MacMillan C; Pintilie M; Payne D; O'Sullivan B; Cummings BJ; Warde P; Liu FF
    Cancer; 2002 Apr; 94(7):1997-2006. PubMed ID: 11932902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection of human papillomavirus (HPV) and Epstein-Barr virus (EBV) and p53 expression in human esophageal carcinoma.
    Khurshid A; Kazuya N; Hanae I; Manabu I
    J Pak Med Assoc; 1998 May; 48(5):138-42. PubMed ID: 9813975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.